![John Pottage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Pottage
Direktor/Vorstandsmitglied bei
SPERO THERAPEUTICS, INC.
Vermögen: 165 750 $ am 30.06.2026
Profil
John C.
Pottage is currently Director at Global Virus Network since 2022, Director at Spero Therapeutics, Inc. since 2018, and Member-Global Safety Board at MMV Medicines for Malaria Venture.
Former positions include Director at Pardes Biosciences, Inc. from 2022 to 2023, SVP, Chief Scientific & Medical Officer at ViiV Healthcare Ltd. from 2009 to 2019, SVP & Head-Infectious Disease Medicine Development at GlaxoSmithKline LLC from 2008 to 2009, Chief Medical Officer & Senior Vice President at Achillion Pharmaceuticals, Inc. from 2002 to 2007, Medical Director at Vertex Pharmaceuticals (Canada), Inc. from 1998 to 2002, Associate Professor at Rush Medical College, and a role at Coopers & Lybrand LLP in 2004.
Education includes undergraduate studies at Colgate University and a doctorate from Saint Louis University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,13 % | 23.06.2026 | 75 000 ( 0,13 % ) | 165 750 $ | 30.06.2026 |
Aktive Positionen von John Pottage
| Unternehmen | Position | Beginn |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2018 |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Direktor/Vorstandsmitglied | 03.05.2022 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Pottage
| Unternehmen | Position | Ende |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 30.08.2023 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01.11.2009 |
| ACHILLION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.05.2007 |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2002 |
Ausbildung von John Pottage
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Commercial Services |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
